The Eleven Fund

The Eleven Fund is a multi-strategy growth fund focusing on early-stage investments in high-growth companies. Their primary sectors of interest include Technology, Life Sciences, and Consumer. The fund operates in both public and private equity markets, typically participating in Series C and post-IPO equity rounds.

Founded by Hart Wasko, The Eleven Fund has notable investments in companies such as Escient Pharmaceuticals and Pear Therapeutics, both of which have raised significant capital. The fund's investment philosophy centers on identifying and supporting promising early-stage companies with high growth potential across their target sectors.